Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 20-Jun-24 4:19 PM View:  | Schrodinger, Inc. (SDGR) | 18-Jun-24 | Grant | 5,000 | -- | -- | 80% 6.25K to 11.25K | |
| 10-Mar-21 6:18 PM View: | Schrodinger, Inc. (SDGR) | 08-Mar-21 | Option Exercise | 28,775 | $10.55 | $303,479.00 | 100% 0 to 28.77K | |
| 10-Mar-21 6:18 PM View: | Schrodinger, Inc. (SDGR) | 08-Mar-21 | Market Option Sale | 28,775 | $66.55 | $1,914,840.00 | (100%) 28.77K to 0 | |
| 02-Mar-21 7:43 PM View: | Nabriva Therapeutics Plc (NBRV) | 28-Feb-21 | Payment of Exercise | 31 | $2.39 | $74.09 | (< 1%) 20.5K to 20.47K | 20% |
| 02-Feb-21 8:01 PM View: | Nabriva Therapeutics Plc (NBRV) | 31-Jan-21 | Payment of Exercise | 37 | $2.62 | $96.94 | (< 1%) 20.54K to 20.5K | (< 1%) |
| 05-Jan-21 5:16 PM View: | Nabriva Therapeutics Plc (NBRV) | 31-Dec-20 | Payment of Exercise | 32 | $2.42 | $77.44 | (< 1%) 20.57K to 20.54K | (4%) |
| 01-Dec-20 8:22 PM View: | Nabriva Therapeutics Plc (NBRV) | 30-Nov-20 | Payment of Exercise | 312 | $0.43 | $133.22 | (< 1%) 206.04K to 205.73K | 38% |
| 02-Nov-20 7:07 PM View: | Nabriva Therapeutics Plc (NBRV) | 31-Oct-20 | Payment of Exercise | 312 | $0.50 | $154.60 | (< 1%) 206.35K to 206.04K | 46% |
| 01-Oct-20 4:32 PM View: | Nabriva Therapeutics Plc (NBRV) | 30-Sep-20 | Payment of Exercise | 312 | $0.53 | $166.30 | (< 1%) 206.66K to 206.35K | 50% |
| 02-Sep-20 5:16 PM View: | Nabriva Therapeutics Plc (NBRV) | 31-Aug-20 | Payment of Exercise | 312 | $0.62 | $193.25 | (< 1%) 206.98K to 206.66K | 57% |
| 21-Aug-20 7:02 PM View: | Nabriva Therapeutics Plc (NBRV) | 20-Aug-20 | Payment of Exercise | 3,204 | $0.65 | $2,074.91 | (2%) 210.18K to 206.98K | 59% |
| 21-Aug-20 7:02 PM View: | Nabriva Therapeutics Plc (NBRV) | 19-Aug-20 | Option Exercise | 11,250 | -- | -- | 6% 198.93K to 210.18K | |
| 04-Aug-20 4:07 PM View: | Nabriva Therapeutics Plc (NBRV) | 31-Jul-20 | Payment of Exercise | 312 | $0.76 | $237.12 | (< 1%) 199.24K to 198.93K | 65% |
| 02-Jul-20 4:06 PM View: | Nabriva Therapeutics Plc (NBRV) | 30-Jun-20 | Payment of Exercise | 312 | $0.67 | $210.48 | (< 1%) 199.55K to 199.24K | 59% |
| 03-Jun-20 6:08 AM View: | Nabriva Therapeutics Plc (NBRV) | 31-May-20 | Payment of Exercise | 312 | $1.14 | $355.68 | (< 1%) 199.87K to 199.55K | 76% |
| 04-May-20 6:32 PM View: | Nabriva Therapeutics Plc (NBRV) | 30-Apr-20 | Payment of Exercise | 301 | $0.55 | $165.04 | (< 1%) 193.98K to 193.68K | 49% |
| 02-Apr-20 5:49 PM View: | Nabriva Therapeutics Plc (NBRV) | 31-Mar-20 | Payment of Exercise | 301 | $0.57 | $173.07 | (< 1%) 194.28K to 193.98K | 53% |
| 03-Mar-20 9:32 PM View: | Nabriva Therapeutics Plc (NBRV) | 28-Feb-20 | Payment of Exercise | 301 | $1.35 | $406.35 | (< 1%) 194.58K to 194.28K | 80% |
| 10-Feb-20 8:29 PM View: | Nabriva Therapeutics Plc (NBRV) | 06-Feb-20 | Grant | 105,000 | -- | -- | 133% 78.67K to 183.67K | |
| 04-Feb-20 8:56 PM View: | Nabriva Therapeutics Plc (NBRV) | 31-Jan-20 | Payment of Exercise | 4,295 | $1.35 | $5,798.25 | (3%) 165.93K to 161.63K | 80% |
| 21-Aug-19 9:22 PM View: | Nabriva Therapeutics Plc (NBRV) | 21-Aug-19 | Payment of Exercise | 3,390 | $2.08 | $7,051.20 | (15%) 22.6K to 19.21K | 87% |
| 21-Aug-19 9:22 PM View: | Nabriva Therapeutics Plc (NBRV) | 19-Aug-19 | Option Exercise | 11,250 | -- | -- | 99% 11.35K to 22.6K | |
| 23-May-18 8:38 PM View: | Nabriva Therapeutics Plc (NBRV) | 23-May-18 | Market Purchase | 2,000 | $4.57 | $9,140.00 | 48% 4.2K to 6.2K | (94%) |
| 26-Sep-17 5:01 PM View: | Nabriva Therapeutics Plc (NBRV) | 22-Sep-17 | Market Purchase | 2,000 | $8.21 | $16,420.00 | 91% 2.2K to 4.2K | (97%) |
| 28-Jun-17 6:01 AM View: | Nabriva Therapeutics Legacy... (NBRV) | 23-Jun-17 | Acquisition (other) | 2,200 | -- | -- | 100% 0 to 2.2K |